Your doctor will check if you meet the study requirements, including age (between 40 and 85 years), diagnosis of COPD for more than 12 months, and smoking history of at least 10 pack-years

Your breathing capacity will be tested to confirm that you meet specific lung function criteria

Your current medications will be reviewed to ensure you have been using required breathing medications for at least 3 months

You will be randomly assigned to receive either Verekitug or a placebo

The medication will be given through an injection under the skin (subcutaneous injection)

You will continue using your regular breathing medications during the study

Your lung function will be tested regularly

You will complete questionnaires about your breathing symptoms

Any breathing problems or other health issues will be recorded

Blood samples will be taken to measure medication levels in your body

Continued monitoring of your COPD symptoms and any breathing difficulties

Regular checks for any side effects

Blood tests to check for antibodies to the study medication

Final assessment of how often you experienced moderate or severe breathing problems during the study

Final medical examination and tests

Review of your overall health and COPD status

Documentation of any remaining side effects or health concerns